| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.095 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |